HUP9901688A3 - Novel peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits - Google Patents

Novel peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits

Info

Publication number
HUP9901688A3
HUP9901688A3 HU9901688A HUP9901688A HUP9901688A3 HU P9901688 A3 HUP9901688 A3 HU P9901688A3 HU 9901688 A HU9901688 A HU 9901688A HU P9901688 A HUP9901688 A HU P9901688A HU P9901688 A3 HUP9901688 A3 HU P9901688A3
Authority
HU
Hungary
Prior art keywords
kits
diabetes
compositions
treatment
methods
Prior art date
Application number
HU9901688A
Other languages
English (en)
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of HUP9901688A2 publication Critical patent/HUP9901688A2/hu
Publication of HUP9901688A3 publication Critical patent/HUP9901688A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HU9901688A 1995-06-30 1996-07-01 Novel peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits HUP9901688A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL11440795A IL114407A0 (en) 1995-06-30 1995-06-30 Novel peptides and pharmaceutical compositions comprising them

Publications (2)

Publication Number Publication Date
HUP9901688A2 HUP9901688A2 (hu) 1999-09-28
HUP9901688A3 true HUP9901688A3 (en) 1999-12-28

Family

ID=11067704

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9901688A HUP9901688A3 (en) 1995-06-30 1996-07-01 Novel peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits

Country Status (19)

Country Link
US (1) US6682897B1 (hu)
EP (1) EP0845943B1 (hu)
KR (1) KR100454554B1 (hu)
CN (1) CN1102598C (hu)
AR (1) AR003446A1 (hu)
AT (1) ATE290315T1 (hu)
AU (1) AU710882B2 (hu)
CA (1) CA2225675C (hu)
CZ (1) CZ295110B6 (hu)
DE (1) DE69634438T2 (hu)
DK (1) DK0845943T3 (hu)
ES (1) ES2239770T3 (hu)
HR (1) HRP960307A2 (hu)
HU (1) HUP9901688A3 (hu)
IL (2) IL114407A0 (hu)
NO (1) NO320715B1 (hu)
UY (1) UY24270A1 (hu)
WO (1) WO1997001959A1 (hu)
ZA (1) ZA965565B (hu)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6488933B2 (en) 1995-07-05 2002-12-03 Yeda Research And Development Co. Ltd. Preparations for the treatment of T cell mediated diseases
EP0914614B1 (en) * 1996-05-14 2003-09-03 Winnacker, Ernst-Ludwig, Prof. CHARPERONES CAPABLE OF BINDING TO PRION PROTEINS AND DISTINGUISHING THE ISOFORMS PrPc AND PrPsc
US5993803A (en) * 1996-08-30 1999-11-30 Yeda Research And Development Co., Ltd. Method of reducing the severity of host vs graft reaction by down-regulating hsp60 autoimmunity
CA2394504A1 (en) * 1999-12-15 2001-06-21 Peptor Ltd. Fragments and antagonists of heat shock protein 60
EP1335741A4 (en) * 2000-08-25 2005-10-26 Yeda Res & Dev METHOD FOR THE PREVENTION OF AUTOIMMUNE DISEASES WITH CpG-CONTAINING POLYNUCLEOTIDES (04.03.02)
EP2157101B1 (en) 2002-01-31 2014-09-24 Andromeda Bio Tech Ltd. HSP peptides and analogs for modulation of immune responses via antigen presenting cells
WO2003070761A1 (en) * 2002-02-19 2003-08-28 Yeda Research And Development Co. Ltd. Dual-effect ligands comprising anti-inflammatory hsp peptide epitopes for immunomodulation
AU2003230181A1 (en) 2002-05-21 2003-12-02 Yeda Research And Development Co. Ltd. Dna vaccines encoding heat shock proteins
WO2004098489A2 (en) * 2003-05-12 2004-11-18 Peptor Ltd. Compositions and methods for modulation of specific epitopes of hsp60
WO2005048914A2 (en) * 2003-11-24 2005-06-02 Yeda Research & Development Co. Ltd. Dna vaccines encoding hsp60 peptide fragments for treating autoimmune diseases
EP1718158B1 (en) 2004-01-28 2014-07-02 Andromeda Bio Tech Ltd. Hsp therapy in conjunction with a low antigenicity diet
WO2006072946A2 (en) 2005-01-04 2006-07-13 Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science Hsp60, hsp60 peptides and t cell vaccines for immunomodulation
CU23701A1 (es) 2008-12-29 2011-09-21 Ct Ingenieria Genetica Biotech Método de tratamiento de enfermedades inflamatorias intestinales y diabetes tipo i
US9102942B2 (en) 2010-02-04 2015-08-11 EWHA University—Industry Collaboration Foundation Pharmaceutical composition for inhibiting abnormal proliferation of cells
ITCO20120007A1 (it) * 2012-02-21 2013-08-22 Nuovo Pignone Srl Dispositivo di filtraggio dell'aria in ingresso per un impianto
WO2013128453A1 (en) 2012-03-01 2013-09-06 Yeda Research And Development Co. Ltd. Regeneration of islet beta cells by hsp60 derived peptides
WO2013128450A1 (en) 2012-03-01 2013-09-06 Yeda Research And Development Co. Ltd. Hsp60 derived peptides and peptide analogs for suppression and treatment of non-autoimmune diabetes
WO2017189988A1 (en) * 2016-04-29 2017-11-02 Araim Pharmaceuticals, Inc. Tissue protective peptides for preventing and treating diseases and disorders associated with tissue damage
CN111035755B (zh) * 2020-01-08 2023-04-14 中国医学科学院医学生物学研究所 一种1型糖尿病疫苗及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242823A (en) * 1986-03-07 1993-09-07 International Genetic Engineering, Inc. Cloning of the 38kd Mycoplasma hyorhinis regression-associated antigen
US4976958A (en) * 1987-02-26 1990-12-11 Scripps Clinic And Research Foundation Mycobacterial recombinants and peptides
US5114844A (en) * 1989-03-14 1992-05-19 Yeda Research And Development Co., Ltd. Diagnosis and treatment of insulin dependent diabetes mellitus

Also Published As

Publication number Publication date
EP0845943A1 (en) 1998-06-10
EP0845943B1 (en) 2005-03-09
CN1193889A (zh) 1998-09-23
IL122757A0 (en) 1998-08-16
IL114407A0 (en) 1995-10-31
KR100454554B1 (ko) 2005-04-06
DK0845943T3 (da) 2005-07-11
JP3955627B2 (ja) 2007-08-08
ATE290315T1 (de) 2005-03-15
AU6484596A (en) 1997-02-05
CN1102598C (zh) 2003-03-05
CA2225675A1 (en) 1997-01-23
DE69634438T2 (de) 2006-02-09
UY24270A1 (es) 2000-12-29
ZA965565B (en) 1997-02-26
US6682897B1 (en) 2004-01-27
EP0845943A4 (en) 2002-04-10
NO976094L (no) 1998-02-02
CZ295110B6 (cs) 2005-05-18
ES2239770T3 (es) 2005-10-01
WO1997001959A1 (en) 1997-01-23
AR003446A1 (es) 1998-08-05
JPH11509196A (ja) 1999-08-17
CA2225675C (en) 2010-09-21
AU710882B2 (en) 1999-09-30
DE69634438D1 (de) 2005-04-14
CZ411797A3 (cs) 1998-06-17
KR19990028640A (ko) 1999-04-15
IL122757A (en) 2001-07-24
NO320715B1 (no) 2006-01-23
MX9800191A (es) 1998-05-31
HUP9901688A2 (hu) 1999-09-28
NO976094D0 (no) 1997-12-29
HRP960307A2 (en) 1998-04-30

Similar Documents

Publication Publication Date Title
HUP9901688A3 (en) Novel peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits
ZA989461B (en) Methods and compositions for the treatment of autoimmune disease using heat shock proteins
PL314051A1 (en) Recombined obesity proteins (ob), fusion proteins, expression vectors, sequential dnas, transformed e, collie cells, method of obtaining recombined human or mouse's obesity protein and pharmaceutic composition
EP0808324A4 (en) COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING CARDIOVASCULAR DISEASES
EP1285664A3 (en) Methods of increasing lean tissue mass using OB protein compositions
ZA964733B (en) Ob protein compositions and methods
ZA966240B (en) Methods for treatment of allergic asthma.
AU7068896A (en) Protein composition derived from sesame seed and use thereof
US5656608B1 (en) Amino acid compositions and methods of treatment using same
ZA961948B (en) 6-aryl pyrazoloÚ3,4-d¾pyrimidin-4-ones and compositions and methods of use thereof
AU5605398A (en) Novel methods and compositions for treatment of autoimmune diseases
WO1999014241A3 (en) Compositions and methods for the treatment of immune related diseases
AU2467395A (en) Novel ophthalmologic uses of protein c
PL316486A1 (en) Novel sulphonamides, method of obtaining them and therapeutic agent containing them
WO2001040465A3 (en) Compositions and methods for the treatment of immune related diseases
HUP9901204A3 (en) Novel protein hmw human mp52
PL324822A1 (en) Human protein mp52 arg
AU6786598A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
WO2000015797A3 (en) Compositions and methods for the treatment of immune related diseases
AUPN115095A0 (en) Analysis of and compositions and methods for the treatment of disease
AU6786798A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU6038196A (en) Compositions and methods of treating il-6 associated disease s
AU7478098A (en) Methods of treatment using nbs-1, antibodies and proteins thereto, and uses of the antibodies
AU6786698A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
WO2001016319A3 (en) Compositions and methods for the treatment of immune related diseases

Legal Events

Date Code Title Description
FC4A Lapse of provisional application due to refusal